• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以色列南部一项多方位干预策略根除医院广泛传播的耐碳青霉烯类肺炎克雷伯菌爆发

A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel.

机构信息

Infection Control and Hospital Epidemiology Unit, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

出版信息

Infect Control Hosp Epidemiol. 2011 Dec;32(12):1158-65. doi: 10.1086/662620. Epub 2011 Oct 17.

DOI:10.1086/662620
PMID:22080653
Abstract

OBJECTIVE

To devise a local strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae (CRKP).

DESIGN

Quasi-experimental, before-and-after, interrupted time-series study.

SETTING

A 1,000-bed tertiary-care university teaching hospital.

METHODS

Retrospectively, all relevant data were collected from the medical records of patients with CRKP infections from May 2006 through April 2007, the preintervention period. From May 1, 2007, through May 1, 2010, the postintervention period, the intervention was applied and prospectively followed. The 5 key elements of this strategy were an emergency department flagging system, the building of a cohort ward, the eradication of clusters, environmental and personnel hand cultures, and a carbapenem-restriction policy. The demographic and clinical parameters of patients colonized by and/or infected with CRKP were collected from medical records.

RESULTS

A total of 10,680 rectal cultures were performed for 8,376 patients; 433 (5.16%) and 370 (4.4%) were CRKP-colonized and CRKP-infected patients, respectively, and 789 (98%) of 803 patients were admitted to the CRKP cohort ward. The CRKP infection density was reduced from 5.26 to 0.18 per 10,000 patient-days (P ≤ .001), and no nosocomial CRKP infections were diagnosed. Twenty-three percent of environmental cultures were found to be positive. Meropenem use was reduced from 283 ± 70.92 to 118 ± 74.32 defined daily doses per 1,000 patient-days (P ≤ .001).

CONCLUSION

This intervention produced an enormous impact on patient location, surveillance cultures, and antibiotic policies and a massive investment in infection control resources.

摘要

目的

制定一项局部策略,以消除由耐碳青霉烯类肺炎克雷伯菌(CRKP)引起的医院范围内的暴发。

设计

准实验、前后、中断时间序列研究。

地点

一家拥有 1000 张床位的三级教学医院。

方法

回顾性地从 2006 年 5 月至 2007 年 4 月期间患有 CRKP 感染的患者的病历中收集所有相关数据,这是干预前时期。从 2007 年 5 月 1 日至 2010 年 5 月 1 日,应用干预措施并进行前瞻性随访,这是干预后时期。该策略的 5 个关键要素包括急诊部标记系统、建立队列病房、消除集群、环境和人员手培养以及碳青霉烯类限制政策。从病历中收集了定植和/或感染 CRKP 的患者的人口统计学和临床参数。

结果

对 8376 名患者进行了 10680 次直肠培养,其中 433(5.16%)和 370(4.4%)为 CRKP 定植和 CRKP 感染患者,803 名患者中的 789 名(98%)被收入 CRKP 队列病房。CRKP 感染密度从 5.26 降至 0.18/10000 患者日(P ≤.001),且未诊断出医院内 CRKP 感染。23%的环境培养呈阳性。美罗培南使用量从 283 ± 70.92 定义日剂量/1000 患者日降至 118 ± 74.32 定义日剂量/1000 患者日(P ≤.001)。

结论

该干预措施对患者位置、监测培养物和抗生素政策以及对感染控制资源的大量投资产生了巨大影响。

相似文献

1
A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel.以色列南部一项多方位干预策略根除医院广泛传播的耐碳青霉烯类肺炎克雷伯菌爆发
Infect Control Hosp Epidemiol. 2011 Dec;32(12):1158-65. doi: 10.1086/662620. Epub 2011 Oct 17.
2
Institutional control measures to curtail the epidemic spread of carbapenem-resistant Klebsiella pneumoniae: a 4-year perspective.采取机构控制措施遏制碳青霉烯类耐药肺炎克雷伯菌的流行:4 年展望。
Infect Control Hosp Epidemiol. 2011 Jul;32(7):673-8. doi: 10.1086/660358.
3
Infection-prevention and control interventions to reduce colonisation and infection of intensive care unit-acquired carbapenem-resistant : a 4-year quasi-experimental before-and-after study.感染预防和控制干预措施以减少 ICU 获得性耐碳青霉烯类肠杆菌科细菌定植和感染:一项为期 4 年的准实验前后研究。
Antimicrob Resist Infect Control. 2019 Jan 10;8:8. doi: 10.1186/s13756-018-0453-7. eCollection 2019.
4
Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel.以色列急性后期护理机构中耐碳青霉烯类肺炎克雷伯菌。
Infect Control Hosp Epidemiol. 2011 Sep;32(9):845-53. doi: 10.1086/661279.
5
Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection.主动监测在控制医院范围内耐碳青霉烯类肺炎克雷伯菌感染爆发中的潜在作用。
Infect Control Hosp Epidemiol. 2010 Jun;31(6):620-6. doi: 10.1086/652528.
6
Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenem-resistant K pneumoniae.耐碳青霉烯类肺炎克雷伯菌定植患者中发生耐碳青霉烯类肺炎克雷伯菌临床感染的危险因素。
Am J Infect Control. 2012 Jun;40(5):421-5. doi: 10.1016/j.ajic.2011.05.022. Epub 2011 Sep 9.
7
An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice.在急症护理环境中限制流行碳青霉烯类耐药肺炎克雷伯菌菌株传播的有效干预措施:从理论到实践。
Am J Infect Control. 2011 Oct;39(8):671-677. doi: 10.1016/j.ajic.2011.05.004. Epub 2011 Aug 23.
8
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.耐碳青霉烯类肺炎克雷伯菌医院感染的危险因素
South Med J. 2011 Feb;104(2):106-10. doi: 10.1097/SMJ.0b013e318206063d.
9
Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention.通过在全国范围内实施干预措施,遏制以色列医院耐碳青霉烯类肺炎克雷伯菌的全国性爆发。
Clin Infect Dis. 2011 Apr 1;52(7):848-55. doi: 10.1093/cid/cir025. Epub 2011 Feb 11.
10
Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.碳青霉烯类耐药对肺炎克雷伯菌引起的医院获得性菌血症患者结局的影响。
J Hosp Infect. 2013 Apr;83(4):307-13. doi: 10.1016/j.jhin.2012.10.012. Epub 2013 Jan 10.

引用本文的文献

1
Risk Factors and Outcomes of Patients Colonized with KPC and NDM Carbapenemase-Producing Enterobacterales.携带产KPC和NDM碳青霉烯酶肠杆菌科细菌患者的危险因素及转归
Antibiotics (Basel). 2024 May 8;13(5):427. doi: 10.3390/antibiotics13050427.
2
Bactericidal, anti-biofilm, and anti-virulence activity of vitamin C against carbapenem-resistant hypervirulent .维生素C对耐碳青霉烯类高毒力菌的杀菌、抗生物膜及抗毒力活性
iScience. 2022 Feb 8;25(3):103894. doi: 10.1016/j.isci.2022.103894. eCollection 2022 Mar 18.
3
Risk Factors for a Hospital-Acquired Carbapenem-Resistant Bloodstream Infection: A Five-Year Retrospective Study.
医院获得性耐碳青霉烯血流感染的危险因素:一项五年回顾性研究。
Infect Drug Resist. 2022 Feb 25;15:641-654. doi: 10.2147/IDR.S342103. eCollection 2022.
4
Antimicrobial stewardship and infection prevention interventions targeting healthcare-associated and carbapenem-resistant infections: a scoping review.针对医疗保健相关和碳青霉烯类耐药感染的抗菌药物管理和感染预防干预措施:范围综述。
BMJ Open. 2021 Aug 4;11(8):e051983. doi: 10.1136/bmjopen-2021-051983.
5
Impact of multimodal strategies to reduce multidrug-resistant organisms in surgical intensive care units: Knowledge, practices and transmission: A quasi-experimental study.多模式策略对降低外科重症监护病房多重耐药菌的影响:知识、实践与传播:一项准实验研究
Nurs Open. 2021 Jul;8(4):1937-1946. doi: 10.1002/nop2.864. Epub 2021 Mar 24.
6
Use of interrupted time series methods in the evaluation of health system quality improvement interventions: a methodological systematic review.运用中断时间序列法评估卫生系统质量改进干预措施:方法学系统评价。
BMJ Glob Health. 2020 Oct;5(10). doi: 10.1136/bmjgh-2020-003567.
7
Containing Carbapenemase-producing Klebsiella pneumoniae in an endemic setting.在流行地区含有产碳青霉烯酶肺炎克雷伯菌。
Antimicrob Resist Infect Control. 2020 Jul 6;9(1):102. doi: 10.1186/s13756-020-00766-x.
8
Successful control of the first carbapenem-resistant Klebsiella pneumoniae outbreak in a Chinese hospital 2017-2019.成功控制 2017-2019 年中国医院的首例碳青霉烯类耐药肺炎克雷伯菌爆发
Antimicrob Resist Infect Control. 2020 Jun 22;9(1):91. doi: 10.1186/s13756-020-00757-y.
9
Prevention and control of intensive care unit-acquired carbapenem-resistant Klebsiella pneumoniae: need for a multimodal approach.重症监护病房获得性耐碳青霉烯类肺炎克雷伯菌的预防与控制:需要采取多模式方法。
Ann Transl Med. 2019 Dec;7(Suppl 8):S325. doi: 10.21037/atm.2019.09.130.
10
Carbapenem-Resistant Enterobacteriaceae in Solid Organ Transplantation: Management Principles.实体器官移植中耐碳青霉烯类肠杆菌科细菌:管理原则
Curr Infect Dis Rep. 2019 Jun 10;21(7):26. doi: 10.1007/s11908-019-0679-4.